Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02650804
Title BPM31510 Administered Intravenously With or Without Gemcitabine in Advanced Pancreatic Cancer Patients
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Berg, LLC

pancreatic adenocarcinoma


BPM 31510

BPM 31510 + Gemcitabine

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Banner Health Gilbert Arizona 85234 United States Details
Mayo Clinic Phoenix Arizona 85259-5499 United States Details
Global Cancer Research Institute, Inc. Gilroy California 95020 United States Details
Sarcoma Oncology Research Center Santa Monica California 90403 United States Details
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 United States Details
Atlantic Health System Morristown Medical Center Morristown New Jersey 07962 United States Details
Vita Medical Associates, P.C. Bethlehem Pennsylvania 18015 United States Details
Mary Crowley Cancer Research Center Dallas Texas 75230 United States Details
Medical College of Wisconsin Milwaukee Wisconsin 53226 United States Details
The Beatson West of Scotland Cancer Centre Glasgow Strathclyde G12 0YN United Kingdom Details
St Bartholomew's Hospital London EC1A 7BE United Kingdom Details
Royal Free London NHS Foundation Trust London NW3 2PF United Kingdom Details
*Shaded cells indicate that there was no data available from for the field